XML 41 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of significant accounting policies and basis of presentation (Tables)
12 Months Ended
Dec. 31, 2023
Summary of significant accounting policies and basis of presentation  
Schedule of money market funds and marketable securities

Cash, cash equivalents, and marketable securities as of December 31, 2023 and 2022 consist of the following:

Amortized

Unrealized

Unrealized

Fair

 

    

Cost

    

Gains

    

Losses

    

Value

 

(in thousands)

 

As of December 31, 2023

    

    

    

    

    

    

    

Money market funds included in cash and cash equivalents

    

$

65,589

$

65,589

Marketable securities:

U.S. Treasury notes

102,966

81

(3)

103,044

U.S. Government agency securities

31,068

10

(3)

31,075

Corporate bonds

23,975

2

(7)

23,970

Commercial paper

3,985

3,985

Total money market funds and marketable securities

    

$

227,583

$

93

$

(13)

$

227,663

As of December 31, 2022

    

    

    

    

    

    

    

    

Money market funds included in cash and cash equivalents

    

$

91,724

$

$

$

91,724

Marketable securities:

    

U.S. Treasury notes

    

19,980

(91)

19,889

Total money market funds and marketable securities

    

$

111,704

$

$

(91)

$

111,613

Reconciliation of cash, cash equivalents, and restricted cash

As of December 31, 

2023

    

2022

    

2021

(in thousands)

Cash and cash equivalents

$

68,802

$

98,959

$

117,433

Restricted cash included in deposits and other non-current assets

1,593

1,515

1,779

Total cash, cash equivalents, and restricted cash

$

70,395

$

100,474

$

119,212

Outstanding potentially dilutive securities excluded in the calculation of diluted net income (loss) per share

The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted net income (loss) per share because to do so would be anti-dilutive:

As of December 31, 

    

2023

    

2022

    

2021

Unvested restricted common stock awards

 

22,500

 

45,000

 

137,255

Unvested restricted common stock units

1,370,897

1,112,563

806,379

Outstanding stock options

 

7,425,444

 

6,199,571

 

5,013,193

Total

 

8,818,841

 

7,357,134

 

5,956,827

Schedule of weighted average number of shares, basic and diluted

Year Ended December 31, 

2023

2022

2021

(in thousands, except share data)

Numerator:

Net income (loss)

$

132,330

$

(46,408)

$

(71,197)

Denominator for basic net income (loss) per share:

Weighted average shares outstanding-basic

43,020,747

38,356,810

37,668,947

Denominator for diluted net income (loss) per share:

Weighted average shares outstanding

43,020,747

38,356,810

37,668,947

Common stock options and restricted stock units

1,548,587

Weighted average shares outstanding-diluted

44,569,334

38,356,810

37,668,947